Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Curcumin Inhibits Proliferation of Leukemic Cells Expressing P210BCR-ABL or BCR-ABL-T315I and Prolongs Survival of Mice with B-Cell Acute Lymphoblastic Leukemia (B-ALL).

Basem M. William, MD, Ami Goodrich, Cong Peng, MS, Shaoguang Li, MD, PhD

Blood (2006) 108 (11): 1887.

https://doi.org/10.1182/blood.V108.11.1887.1887

Published: 2006

Journal Articles

Immunodominant Minor Histocompatibility Antigen-Specific T Lymphocytes Eradicate BCR-ABL-Induced B-ALL and CML without Causing Graft-Versus-Host Disease in Mice.

Yiguo Hu, MD, Thomas Sproule, BS, Cong Peng, MS, Linghong Kong, MD, PhD, Ami Goodrich, Derry Roopenian, PhD, Shaoguang Li, MD, PhD

Blood (2006) 108 (11): 3686.

https://doi.org/10.1182/blood.V108.11.3686.3686

Published: 2006

Journal Articles

Increase in Leukemic Stem Cells Is Associated with Acceleration of BCR-ABL-Induced CML in P-Selectin-Deficient Mice.

Linghong Kong, MD, PhD, Yiguo Hu, MD, Cong Peng, MS, Zhu Wang, Ted Duffy, PhD, Ami Goodrich, Shaoguang Li, MD, PhD

Blood (2006) 108 (11): 2129.

https://doi.org/10.1182/blood.V108.11.2129.2129

Published: 2006

Journal Articles

IPI-504, a Novel, Orally Active HSP90 Inhibitor, Prolongs Survival of Mice with BCR-ABL T315I CML and B-ALL.

Cong Peng, MS, Julia Brain, PhD, Yiguo Hu, MD, Linghong Kong, MD, PhD, David Grayzel, MD, Roger Pak, PhD, Margaret Read, PhD, Shaoguang Li, MD, PhD

Blood (2006) 108 (11): 2183.

https://doi.org/10.1182/blood.V108.11.2183.2183

Published: 2006

Journal Articles

Hsp-90 Inhibition Decreases Survival of BCR-ABL T315I Leukemic Stem Cells in Mice.

Cong Peng, MS, Julia Brain, PhD, Yiguo Hu, MD, Linghong Kong, MD, PhD, Ami Goodrich, David Grayzel, MD, Roger Pak, PhD, Margaret Read, PhD, Shaoguang Li, MD, PhD

Blood (2006) 108 (11): 2184.

https://doi.org/10.1182/blood.V108.11.2184.2184

Published: 2006

Journal Articles

Targeting Chronic Myeloid Leukemia (CML) Stem Cells by BMS-214662 in Mice.

Cong Peng, MS, Yiguo Hu, MD, Francis Y. Lee, PhD, Shaoguang Li, MD, PhD

Blood (2005) 106 (11): 2861.

https://doi.org/10.1182/blood.V106.11.2861.2861

Published: 2005

NARROW

Curcumin Inhibits Proliferation of Leukemic Cells Expressing P210BCR-ABL or BCR-ABL-T315I and Prolongs Survival of Mice with B-Cell Acute Lymphoblastic Leukemia (B-ALL).

Immunodominant Minor Histocompatibility Antigen-Specific T Lymphocytes Eradicate BCR-ABL-Induced B-ALL and CML without Causing Graft-Versus-Host Disease in Mice.

Increase in Leukemic Stem Cells Is Associated with Acceleration of BCR-ABL-Induced CML in P-Selectin-Deficient Mice.

IPI-504, a Novel, Orally Active HSP90 Inhibitor, Prolongs Survival of Mice with BCR-ABL T315I CML and B-ALL.

Hsp-90 Inhibition Decreases Survival of BCR-ABL T315I Leukemic Stem Cells in Mice.

Targeting Chronic Myeloid Leukemia (CML) Stem Cells by BMS-214662 in Mice.

Email alerts

ASH Publications

American Society of Hematology

Curcumin Inhibits Proliferation of Leukemic Cells Expressing P210BCR-ABL or BCR-ABL-T315I and Prolongs Survival of Mice with B-Cell Acute Lymphoblastic Leukemia (B-ALL).

Immunodominant Minor Histocompatibility Antigen-Specific T Lymphocytes Eradicate BCR-ABL-Induced B-ALL and CML without Causing Graft-Versus-Host Disease in Mice.

Increase in Leukemic Stem Cells Is Associated with Acceleration of BCR-ABL-Induced CML in P-Selectin-Deficient Mice.

IPI-504, a Novel, Orally Active HSP90 Inhibitor, Prolongs Survival of Mice with BCR-ABL T315I CML and B-ALL.

Hsp-90 Inhibition Decreases Survival of BCR-ABL T315I Leukemic Stem Cells in Mice.

Targeting Chronic Myeloid Leukemia (CML) Stem Cells by BMS-214662 in Mice.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only